Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 4/2018

01-10-2018 | Maternal-Fetal Medicine

FTO, GCKR, CDKAL1 and CDKN2A/B gene polymorphisms and the risk of gestational diabetes mellitus: a meta-analysis

Authors: Fang Guo, Wei Long, Wenbai Zhou, Bin Zhang, Jianbing Liu, Bin Yu

Published in: Archives of Gynecology and Obstetrics | Issue 4/2018

Login to get access

Abstract

Purpose

Studies had examined the associations between genetic polymorphisms and the risk of gestational diabetes mellitus (GDM). However, conclusions of these studies were controversial due to the smaller sample size and limited statistical power. We carried out a meta-analysis with the aim of providing a more comprehensive summary of the currently available research to evaluate the relationship between FTO, GCKR, CDKAL1 and CDKN2A/B gene polymorphisms and GDM risk.

Methods

Literature search was carried out in the PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure and Wangfang databases up to November 2017. Data were extracted by two independent reviewers and statistical analyses were performed with STATA software. Pooled odds ratios and 95% confidence intervals were calculated by Z test to assess the association between genetic polymorphisms and GDM risk. Stratified analysis was performed based on ethnicity. Heterogeneity and publication bias between studies were evaluated by Cochran’s Q test and Egger regression test, respectively.

Results

14 eligible studies were included. CDKAL1 rs7754840 and rs7756992 showed significant correlation with GDM risk under the allele, recessive, dominant, homozygote and heterozygote models. GCKR rs780094 and CDKN2A/B rs10811661 also showed the same association under the allele, recessive and heterozygote models. No associations between FTO rs9939609 and rs8050136, GCKR rs1260326 and GDM risk were found.

Conclusions

Our meta-analysis showed that two SNPs in particular(rs7754840 and rs7756992 in CDKAL1) were very strongly associated with GDM risk. GCKR rs780094 and CDKN2A/B rs10811661 polymorphisms were moderately associated with GDM risk.
Appendix
Available only for authorised users
Literature
1.
Reece EA, Leguizamon G, Wiznitzer A (2009) Gestational diabetes: the need for a common ground. Lancet 373(9677):1789–1797CrossRefPubMed
2.
Hadden DR (1985) Geographic, ethnic, and racial variations in the incidence of gestational diabetes mellitus. Diabetes 34(Suppl 2):8–12CrossRefPubMed
3.
4.
Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373(9677):1773–1779CrossRefPubMed
5.
Lauenborg J, Grarup N, Damm P, Borch-Johnsen K, Jorgensen T, Pedersen O, Hansen T (2009) Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab 94(1):145–150CrossRefPubMed
6.
Kasuga Y, Hata K, Tajima A, Ochiai D, Saisho Y, Matsumoto T, Arata N, Miyakoshi K, Tanaka M (2017) Association of common polymorphisms with gestational diabetes mellitus in Japanese women: a case–control study. Endocr J 64(4):463–475CrossRefPubMed
7.
Shaat N, Karlsson E, Lernmark A, Ivarsson S, Lynch K, Parikh H, Almgren P, Berntorp K, Groop L (2006) Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia 49(7):1545–1551CrossRefPubMed
8.
Tarnowski M, Malinowski D, Pawlak K, Dziedziejko V, Safranow K, Pawlik A (2017) GCK, GCKR, FADS1, DGKB/TMEM195 and CDKAL1 gene polymorphisms in women with gestational diabetes. Can J Diabetes 41(4):372–379CrossRefPubMed
9.
Tarnowski M, Malinowski D, Safranow K, Dziedziejko V, Pawlik A (2017) CDC123/CAMK1D gene rs12779790 polymorphism and rs10811661 polymorphism upstream of the CDKN2A/2B gene in women with gestational diabetes. J Perinatol 37(4):345–348CrossRefPubMed
10.
Chang S, Wang Z, Wu L, Lu X, Shangguan S, Xin Y, Li L, Wang L (2017) Association between TCF7L2 polymorphisms and gestational diabetes mellitus: a meta-analysis. J Diabetes Investig 8(4):560–570CrossRefPubMedPubMedCentral
11.
Wang L, Xu W, Wang X (2016) Peroxisome proliferator-activated receptor Pro12Ala polymorphism and the risks of gestational diabetes mellitus: an updated meta-analysis of 12 studies. Med (Baltimore) 95(44):e5090CrossRef
12.
Liu Q, Huang Z, Li H, Bai J, Liu X, Ye H (2016) Relationship between melatonin receptor 1B (rs10830963 and rs1387153) with gestational diabetes mellitus: a case-control study and meta-analysis. Arch Gynecol Obstet 294(1):55–61CrossRefPubMed
13.
Ao D, Wang HJ, Wang LF, Song JY, Yang HX, Wang Y (2015) The rs2237892 polymorphism in KCNQ1 influences gestational diabetes mellitus and glucose levels: a case–control study and meta-analysis. PLoS One 10(6):e0128901CrossRefPubMedPubMedCentral
14.
Han X, Cui H, Chen X, Xie W, Chang Y (2015) Association of the glucokinase gene promoter polymorphism -30G > A (rs1799884) with gestational diabetes mellitus susceptibility: a case–control study and meta-analysis. Arch Gynecol Obstet 292(2):291–298CrossRefPubMed
15.
Mao H, Li Q, Gao S (2012) Meta-analysis of the relationship between common type 2 diabetes risk gene variants with gestational diabetes mellitus. PLoS One 7(9):e45882CrossRefPubMedPubMedCentral
16.
Zhang C, Bao W, Rong Y, Yang H, Bowers K, Yeung E, Kiely M (2013) Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum Reprod Update 19(4):376–390CrossRefPubMedPubMedCentral
17.
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826):889–894CrossRefPubMedPubMedCentral
18.
Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, Barrett JC, Shields B, Morris AP, Ellard S, Groves CJ, Harries LW, Marchini JL, Owen KR, Knight B, Cardon LR, Walker M, Hitman GA, Morris AD, Doney AS, McCarthy MI, Hattersley AT (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316(5829):1336–1341CrossRefPubMedPubMedCentral
19.
Horikoshi M, Hara K, Ito C, Shojima N, Nagai R, Ueki K, Froguel P, Kadowaki T (2007) Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 50(12):2461–2466CrossRefPubMed
20.
Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Nakamura Y, Maeda S (2008) Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 57(3):791–795CrossRefPubMed
21.
Cho YM, Kim TH, Lim S, Choi SH, Shin HD, Lee HK, Park KS, Jang HC (2009) Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 52(2):253–261CrossRefPubMed
22.
Franzago M, Fraticelli F, Nicolucci A, Celentano C, Liberati M, Stuppia L, Vitacolonna E (2017) Molecular analysis of a genetic variants panel related to nutrients and metabolism: association with susceptibility to gestational diabetes and cardiometabolic risk in affected women. J Diabetes Res 2017:4612623CrossRefPubMedPubMedCentral
23.
Rose CS, Ek J, Urhammer SA, Glumer C, Borch-Johnsen K, Jorgensen T, Pedersen O, Hansen T (2005) A −30G > A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites. Diabetes 54(10):3026–3031CrossRefPubMed
24.
Mohas M, Kisfali P, Jaromi L, Maasz A, Feher E, Csongei V, Polgar N, Safrany E, Cseh J, Sumegi K, Hetyesy K, Wittmann I, Melegh B (2010) GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness? Cardiovasc Diabetol 9:79CrossRefPubMedPubMedCentral
25.
Stuebe AM, Wise A, Nguyen T, Herring A, North KE, Siega-Riz AM (2014) Maternal genotype and gestational diabetes. Am J Perinatol 31(1):69–76PubMed
26.
Ubeda M, Rukstalis JM, Habener JF (2006) Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity. J Biol Chem 281(39):28858–28864CrossRefPubMed
27.
Ching YP, Pang AS, Lam WH, Qi RZ, Wang JH (2002) Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor. J Biol Chem 277(18):15237–15240CrossRefPubMed
28.
Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, Baker A, Snorradottir S, Bjarnason H, Ng MC, Hansen T, Bagger Y, Wilensky RL, Reilly MP, Adeyemo A, Chen Y, Zhou J, Gudnason V, Chen G, Huang H, Lashley K, Doumatey A, So WY, Ma RC, Andersen G, Borch-Johnsen K, Jorgensen T, van Vliet-Ostaptchouk JV, Hofker MH, Wijmenga C, Christiansen C, Rader DJ, Rotimi C, Gurney M, Chan JC, Pedersen O, Sigurdsson G, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39(6):770–775CrossRefPubMed
29.
Pascoe L, Tura A, Patel SK, Ibrahim IM, Ferrannini E, Zeggini E, Weedon MN, Mari A, Hattersley AT, McCarthy MI, Frayling TM, Walker M (2007) Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 56(12):3101–3104CrossRefPubMed
30.
Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE (2006) p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443(7110):453–457CrossRefPubMed
31.
Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M (1999) Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 22(1):44–52CrossRefPubMed
32.
Wei F, Cai C, Feng S, Lv J, Li S, Chang B, Zhang H, Shi W, Han H, Ling C, Yu P, Chen Y, Sun N, Tian J, Jiao H, Yang F, Li M, Wang Y, Zou L, Su L, Li J, Li R, Qiu H, Shi J, Liu S, Chang M, Lin J, Chen L, Li WD (2015) TOX and CDKN2A/B gene polymorphisms are associated with type 2 diabetes in Han Chinese. Sci Rep 5:11900CrossRefPubMedPubMedCentral
33.
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRefPubMed
34.
Bauer T, Bouman HJ, van Werkum JW, Ford NF, ten Berg JM, Taubert D (2011) Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis. BMJ 343:d4588CrossRefPubMedPubMedCentral
35.
36.
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefPubMed
37.
38.
Aris NKM, Ismai NAM, Mahdy ZA, Ahmad S, Naim NM, Siraj HHH, Jaafar R, Ishak S, Harun R, Jamal R (2011) An analysis of targeted single nucleotide polymorphisms for the risk prediction of gestational diabetes mellitus in a cohort of Malaysian patients. Asia-Pacific J Mol Med 1(1):1
39.
Wu Y, Li S, Zhang Z (2015) Association between gene polymorphism of CDKAL1 and gestational diabetes mellitus. Chin J Diabetes 23(6):501–504
40.
Wang Y, Nie M, Li W, Ping F, Hu Y, Ma L, Gao J, Liu J (2011) Association of six single nucleotide polymorphisms with gestational diabetes mellitus in a chinese population. PLoS One 6(11):e26953CrossRefPubMedPubMedCentral
41.
Pagan A, Sabater-Molina M, Olza J, Prieto-Sanchez MT, Blanco-Carnero JE, Parrilla JJ, Gil A, Larque E (2014) A gene variant in the transcription factor 7-like 2 (TCF7L2) is associated with an increased risk of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 180:77–82CrossRefPubMed
42.
de Melo SF, Frigeri HR, dos Santos-Weiss IC, Rea RR, de Souza EM, Alberton D, de Moraes Gomes, Rego F, Picheth G (2015) Polymorphisms in FTO and TCF7L2 genes of Euro-Brazilian women with gestational diabetes. Clin Biochem 48(16–17):1064–1067CrossRefPubMed
43.
Kanthimathi S, Chidambaram M, Liju S, Bhavadharini B, Bodhini D, Prakash VG, Amutha A, Bhavatharini A, Anjana RM, Mohan V, Radha V (2015) Identification of genetic variants of gestational diabetes in South Indians. Diabetes Technol Therapeutics 17(7):462–467CrossRef
44.
Anghebem-Oliveira MI, Webber S, Alberton D, de Souza EM, Klassen G, Picheth G, Rego FG (2017) The GCKR gene polymorphism rs780094 is a risk factor for gestational diabetes in a Brazilian Population. J Clin Lab Anal 31(2):e22035CrossRef
45.
Saucedo R, Valencia J, Gutierrez C, Basurto L, Hernandez M, Puello E, Rico G, Vega G, Zarate A (2017) Gene variants in the FTO gene are associated with adiponectin and TNF-alpha levels in gestational diabetes mellitus. Diabetol Metab Syndr 9(1):32CrossRefPubMedPubMedCentral
46.
Huopio H, Cederberg H, Vangipurapu J, Hakkarainen H, Paakkonen M, Kuulasmaa T, Heinonen S, Laakso M (2013) Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol 169(3):291–297CrossRefPubMed
47.
Kwak SH, Kim SH, Cho YM, Go MJ, Cho YS, Choi SH, Moon MK, Jung HS, Shin HD, Kang HM, Cho NH, Lee IK, Kim SY, Han BG, Jang HC, Park KS (2012) A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes 61(2):531–541CrossRefPubMedPubMedCentral
Metadata
Title
FTO, GCKR, CDKAL1 and CDKN2A/B gene polymorphisms and the risk of gestational diabetes mellitus: a meta-analysis
Authors
Fang Guo
Wei Long
Wenbai Zhou
Bin Zhang
Jianbing Liu
Bin Yu
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 4/2018
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-018-4857-7

Other articles of this Issue 4/2018

Archives of Gynecology and Obstetrics 4/2018 Go to the issue

General Gynecology

Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice

Correction

Correction to: Two-year outcome after recurrent implantation failure: prognostic factors and additional interventions

News and Views

Hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer: a “useless intraoperative fever” or the next hot voice in the surgical management of the “silent killer”?

General Gynecology

Impact of a cervical dysplasia and its treatment on quality of life and sexual function

Maternal-Fetal Medicine

An effect of maternal nifedipine therapy on fetoplacental blood flow: a prospective study

General Gynecology

Instrument usage in laparoscopic gynecologic surgery: a prospective clinical trial